Hao Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hao Hu has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Tao Xu
Department of Urology, Peking University People’s Hospital, Beijing, China
23 shared publicationsChin-Hui Lai
Department of Urology, Peking University People’s Hospital, Beijing, China
17 shared publicationsHaopu Hu
Peking University People’s Hospital
16 shared publicationsMingrui Wang
Department of Urology, Peking University People’s Hospital, Beijing, China
16 shared publicationsJiaxiang Ji
Department of Urology, Peking University People’s Hospital, Beijing, China
12 shared publicationsKexin Xu
Peking University People’s Hospital
12 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 18
Development and prospective multicohort validation of the 7-item ureteral stent symptom questionnaire-short form
Background: The Ureteral Stent Symptom Questionnaire (USSQ) is comprehensive but lengthy, which limits repeated use in routine follow-up and prospective studies. Objectives: To develop a 7-item Ureteral Stent Symptom Questionnaire-Short Form (USSQ-SF) and evaluate its feasibility, reliability, structural validity, responsiveness, and exploratory score interpretation. Design: Single-center prospective multicohort instrument-development and validation study. Methods: We enrolled 1,022 adult patients undergoing ureteral stenting in three sequential phases. Phase 1 (n = 348) used classical test theory, exploratory factor analysis, and regression-based item selection to derive the USSQ-SF from the original USSQ. Phase 2 (n = 412) evaluated reliability, confirmatory factor structure, and exploratory severity strata using overall stent-related bother as the primary anchor. Phase 3 randomized an independent cohort to the original USSQ or USSQ-SF to compare response rate, completion time, and group-level score distributions. Responsiveness, test-retest reliability, and an exploratory medication-anchored change estimate were also assessed. Results: In the Phase 1 derivation cohort, the seven selected items explained 91.7% of the variance in the original USSQ total score (adjusted R2 = 0.917). In two independent USSQ-SF cohorts, confirmatory factor analysis showed high standardized loadings and strong reliability (Cronbach’s alpha = 0.906 and 0.924; composite reliability = 0.932 and 0.952). In the randomized cohort, the USSQ-SF had a higher response rate than the original USSQ (93.3% vs 81.3%) and a shorter completion time (3.17 ± 0.77 vs 13.63 ± 2.32 minutes; p < 0.001). Exploratory severity strata were mild (7-12), moderate (13-19), and severe (20-35). Test-retest reliability was high (ICC = 0.950), and the exploratory medication-anchored improvement threshold was 2.5 points. Conclusion: The USSQ-SF reduced respondent burden and showed supportive reliability, structural validity, and responsiveness in this single-center study. The findings support further external and longitudinal validation of the USSQ-SF as a brief instrument for assessing stent-related symptom burden.
- 12 November 2026
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 18
Open AccessDevelopment and prospective multicohort validation of the 7-item ureteral stent symptom questionnaire-short form
Background: The Ureteral Stent Symptom Questionnaire (USSQ) is comprehensive but lengthy, which limits repeated use in routine follow-up and prospective studies. Objectives: To develop a 7-item Ureteral Stent Symptom Questionnaire-Short Form (USSQ-SF) and evaluate its feasibility, reliability, structural validity, responsiveness, and exploratory score interpretation. Design: Single-center prospective multicohort instrument-development and validation study. Methods: We enrolled 1,022 adult patients undergoing ureteral stenting in three sequential phases. Phase 1 (n = 348) used classical test theory, exploratory factor analysis, and regression-based item selection to derive the USSQ-SF from the original USSQ. Phase 2 (n = 412) evaluated reliability, confirmatory factor structure, and exploratory severity strata using overall stent-related bother as the primary anchor. Phase 3 randomized an independent cohort to the original USSQ or USSQ-SF to compare response rate, completion time, and group-level score distributions. Responsiveness, test-retest reliability, and an exploratory medication-anchored change estimate were also assessed. Results: In the Phase 1 derivation cohort, the seven selected items explained 91.7% of the variance in the original USSQ total score (adjusted R2 = 0.917). In two independent USSQ-SF cohorts, confirmatory factor analysis showed high standardized loadings and strong reliability (Cronbach’s alpha = 0.906 and 0.924; composite reliability = 0.932 and 0.952). In the randomized cohort, the USSQ-SF had a higher response rate than the original USSQ (93.3% vs 81.3%) and a shorter completion time (3.17 ± 0.77 vs 13.63 ± 2.32 minutes; p < 0.001). Exploratory severity strata were mild (7-12), moderate (13-19), and severe (20-35). Test-retest reliability was high (ICC = 0.950), and the exploratory medication-anchored improvement threshold was 2.5 points. Conclusion: The USSQ-SF reduced respondent burden and showed supportive reliability, structural validity, and responsiveness in this single-center study. The findings support further external and longitudinal validation of the USSQ-SF as a brief instrument for assessing stent-related symptom burden.
- Open Access
- 4 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 7199-7205
Therapeutic efficacy of allium stent combined with balloon dilation as a curative modality for benign ureteral strictures: a retrospective clinical outcomes analysis
Objective: To evaluate the Allium stent’s efficacy as a curative treatment for benign ureteral strictures, bridging the gap between endoscopic management and surgical reconstruction. Methods: A retrospective analysis was conducted on 101 patients with benign ureteral strictures treated with Allium stents (2018–2024). Inclusion criteria were benign strictures and complete follow-up data. Treatment success was defined as hydronephrosis improvement, symptom resolution, stability of renal function, and absence of reintervention for at least 12 months postremoval. Outcomes were assessed via ultrasonography at 3-month intervals. Results: The overall curative success rate was 63.36% (64/101), with a median follow-up of 22.5 months (range: 12–50 months). Etiologies included ureteral stones (56.94%), anastomotic strictures (30.69%), polyps (9.9%), and Retroperitoneal Fibrosis (6.95%). A significantly lower success rate was observed in the >2 cm group compared to the ≤2 cm group (48.84% vs. 74.14%, P = 0.01). Multivariate analysis identified anastomotic stricture (OR = 0.347, 95% CI: 0.041–2.886) and stricture length (OR = 0.255, 95% CI: 0.064–0.898) as independent predictors of success. For strictures ≤2 cm, optimal outcomes occurred with 12–24 months’ stent retention (92.86% success). Conclusion: The Allium stent demonstrated satisfactory curative potential for benign ureteral strictures (63.36% curative success rate), particularly in shorter strictures. Etiology and stricture length were independent predictors of success. Twelve to twenty-four months appears as the optimal indwelling duration, offering a viable minimally invasive alternative to reconstruction surgery.
- 4 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 7199-7205
Open AccessTherapeutic efficacy of allium stent combined with balloon dilation as a curative modality for benign ureteral strictures: a retrospective clinical outcomes analysis
Objective: To evaluate the Allium stent’s efficacy as a curative treatment for benign ureteral strictures, bridging the gap between endoscopic management and surgical reconstruction. Methods: A retrospective analysis was conducted on 101 patients with benign ureteral strictures treated with Allium stents (2018–2024). Inclusion criteria were benign strictures and complete follow-up data. Treatment success was defined as hydronephrosis improvement, symptom resolution, stability of renal function, and absence of reintervention for at least 12 months postremoval. Outcomes were assessed via ultrasonography at 3-month intervals. Results: The overall curative success rate was 63.36% (64/101), with a median follow-up of 22.5 months (range: 12–50 months). Etiologies included ureteral stones (56.94%), anastomotic strictures (30.69%), polyps (9.9%), and Retroperitoneal Fibrosis (6.95%). A significantly lower success rate was observed in the >2 cm group compared to the ≤2 cm group (48.84% vs. 74.14%, P = 0.01). Multivariate analysis identified anastomotic stricture (OR = 0.347, 95% CI: 0.041–2.886) and stricture length (OR = 0.255, 95% CI: 0.064–0.898) as independent predictors of success. For strictures ≤2 cm, optimal outcomes occurred with 12–24 months’ stent retention (92.86% success). Conclusion: The Allium stent demonstrated satisfactory curative potential for benign ureteral strictures (63.36% curative success rate), particularly in shorter strictures. Etiology and stricture length were independent predictors of success. Twelve to twenty-four months appears as the optimal indwelling duration, offering a viable minimally invasive alternative to reconstruction surgery.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Genomics
- Vol. 2026 (1) , 5936606
Urinary Microbiota in Female Patients With Dry and Wet Overactive Bladder (OAB)
Purpose: This study is aimed at comparing the urinary microbiota between OAB patients and healthy controls and at assessing whether urinary incontinence status affects the urinary microbiota in OAB patients. Methods: From April 2021 to October 2022, female patients admitted to our hospital in Beijing with an Overactive Bladder Symptom Score (OABSS) greater than 3 were selected. Healthy female individuals were chosen as the control group. Urine specimens were collected and subjected to 16S rRNA sequencing. The data obtained were analyzed using bioinformatics techniques. Results: The average age, OABSS score, and alpha diversity index in the OAB group were significantly higher than those in the control group. At the genus level, the most abundant genus in the OABWet group was Gardnerella (19.69%), and the most abundant genus in the OABDry group was Lactobacillus (12.26%). In the control group, the most abundant genus was also Lactobacillus (19.90%). The OABWet group had significantly higher relative abundances of Gardnerella and Ciliophora compared to the OABDry group, and Ciliophora was more abundant in the control group. Veillonella was less abundant in the OABDry group, while Prevotella and Pseudomonas were less abundant in the control group. Gardnerella was also less abundant in the OABDry group than in the control group. Conclusion: The urinary microbiota of female OAB patients showed lower species richness and lacked dominant bacterial communities compared to the healthy control group. In wet‐type OAB patients, there was not only a decreased abundance of Lactobacillus but also a high abundance of Gardnerella in the urine.
- 1 January 2026
- Published by Wiley in International Journal of Genomics
- Vol. 2026 (1) , 5936606
Open AccessUrinary Microbiota in Female Patients With Dry and Wet Overactive Bladder (OAB)
Purpose: This study is aimed at comparing the urinary microbiota between OAB patients and healthy controls and at assessing whether urinary incontinence status affects the urinary microbiota in OAB patients. Methods: From April 2021 to October 2022, female patients admitted to our hospital in Beijing with an Overactive Bladder Symptom Score (OABSS) greater than 3 were selected. Healthy female individuals were chosen as the control group. Urine specimens were collected and subjected to 16S rRNA sequencing. The data obtained were analyzed using bioinformatics techniques. Results: The average age, OABSS score, and alpha diversity index in the OAB group were significantly higher than those in the control group. At the genus level, the most abundant genus in the OABWet group was Gardnerella (19.69%), and the most abundant genus in the OABDry group was Lactobacillus (12.26%). In the control group, the most abundant genus was also Lactobacillus (19.90%). The OABWet group had significantly higher relative abundances of Gardnerella and Ciliophora compared to the OABDry group, and Ciliophora was more abundant in the control group. Veillonella was less abundant in the OABDry group, while Prevotella and Pseudomonas were less abundant in the control group. Gardnerella was also less abundant in the OABDry group than in the control group. Conclusion: The urinary microbiota of female OAB patients showed lower species richness and lacked dominant bacterial communities compared to the healthy control group. In wet‐type OAB patients, there was not only a decreased abundance of Lactobacillus but also a high abundance of Gardnerella in the urine.
- Open Access
Steerable versus Conventional flexible and navigable suction ureteral access sheath (FANS) flexible Ureteroscopy for Lower Pole stones Treatment: study protocol for a multicentre, randomised superiority trial (SCULPT trial)
Introduction: Flexible ureteroscopy has advanced modern stone management; however, lower pole renal stones remain a challenge due to suboptimal ureteroscope deflection and navigation using conventional flexible and navigable suction ureteral access sheaths (FANS). The SCULPT trial is designed to assess whether the novel steerable FANS—which enables active controlled deflection—can improve the success rate of lower pole access during flexible ureteroscopy. Methods and analysis: This multicentre, prospective, single-blinded, randomised controlled superiority trial will recruit 400 adult patients (aged 18–75 years) with solitary lower pole renal stones ≤2 cm diagnosed by CT from 20 high-volume urological centres in China. Participants will be randomised 1:1 to undergo flexible ureteroscopy with either steerable or conventional FANS. The primary outcome is the success rate of navigating into the lower pole calyx (defined as successful direct stone visualisation, laser lithotripsy and aspiration without adjunct use). Secondary outcomes include immediate and 1 month stone-free rates, operative time, complication profiles (graded by Clavien–Dindo), instrument damage rates, quality-of-life assessments and cost analysis. Statistical analysis will be performed using appropriate tests for continuous and categorical data, with their significance set by prespecified superiority margins. Ethics and dissemination: The study protocol has been designed in accordance with the Declaration of Helsinki and ICH-GCP guidelines. Ethical approval was centrally granted by the Institutional Review Board of The First Affiliated Hospital of Guangzhou Medical University and adopted by all participating centres following local feasibility review. The trial results will be disseminated via peer-reviewed publication and presentation at international conferences. Trial registration number: NCT06898216 .
Open AccessSteerable versus Conventional flexible and navigable suction ureteral access sheath (FANS) flexible Ureteroscopy for Lower Pole stones Treatment: study protocol for a multicentre, randomised superiority trial (SCULPT trial)
Introduction: Flexible ureteroscopy has advanced modern stone management; however, lower pole renal stones remain a challenge due to suboptimal ureteroscope deflection and navigation using conventional flexible and navigable suction ureteral access sheaths (FANS). The SCULPT trial is designed to assess whether the novel steerable FANS—which enables active controlled deflection—can improve the success rate of lower pole access during flexible ureteroscopy. Methods and analysis: This multicentre, prospective, single-blinded, randomised controlled superiority trial will recruit 400 adult patients (aged 18–75 years) with solitary lower pole renal stones ≤2 cm diagnosed by CT from 20 high-volume urological centres in China. Participants will be randomised 1:1 to undergo flexible ureteroscopy with either steerable or conventional FANS. The primary outcome is the success rate of navigating into the lower pole calyx (defined as successful direct stone visualisation, laser lithotripsy and aspiration without adjunct use). Secondary outcomes include immediate and 1 month stone-free rates, operative time, complication profiles (graded by Clavien–Dindo), instrument damage rates, quality-of-life assessments and cost analysis. Statistical analysis will be performed using appropriate tests for continuous and categorical data, with their significance set by prespecified superiority margins. Ethics and dissemination: The study protocol has been designed in accordance with the Declaration of Helsinki and ICH-GCP guidelines. Ethical approval was centrally granted by the Institutional Review Board of The First Affiliated Hospital of Guangzhou Medical University and adopted by all participating centres following local feasibility review. The trial results will be disseminated via peer-reviewed publication and presentation at international conferences. Trial registration number: NCT06898216 .
- 26 September 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (13) , 10358-10359
ASO Author Reflections: Navigating the Dual Threat—Bladder Cancer’s Impact on Upper Tract Urothelial Carcinoma Outcomes
- 26 September 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (13) , 10358-10359
ASO Author Reflections: Navigating the Dual Threat—Bladder Cancer’s Impact on Upper Tract Urothelial Carcinoma Outcomes
- 25 August 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (13) , 10335-10346
Assessing the Influence of Bladder Cancer on Upper Tract Urothelial Carcinoma Prognoses Following Radical Nephroureterectomy: A Retrospective, Propensity Score-Based Multicenter Cohort Study
Bladder cancer (BCa) is relatively common in patients diagnosed with upper tract urothelial carcinoma (UTUC); however, the impact of BCa history on UTUC pr
- 25 August 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (13) , 10335-10346
Assessing the Influence of Bladder Cancer on Upper Tract Urothelial Carcinoma Prognoses Following Radical Nephroureterectomy: A Retrospective, Propensity Score-Based Multicenter Cohort Study
Bladder cancer (BCa) is relatively common in patients diagnosed with upper tract urothelial carcinoma (UTUC); however, the impact of BCa history on UTUC pr
- Open Access
- 10 July 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (12) , 9432-9444
Prognostic Value of the Extent of Lymphadenectomy for Overall Survival Among Patients with Non-muscle Invasive Bladder Cancer, A Retrospective Cohort Study
Background: The purpose of this study was to find out the impact of lymph node dissection (LND) on the prognosis of patients undergoing cystectomy for non-muscle invasive bladder cancer (NMIBC) and determine the minimum number of lymph nodes (LNs) for resection. Patients and Methods: Patients with NMIBC undergoing cystectomy between 2004 and 2015 were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching and multivariate Cox regression analyses were performed to mitigate the influence of selection bias and control for potential confounding variables. Results: Of 1950 patients with NMIBC, 1353 underwent LND, of which 58 (4.2%) exhibited positive LNs. LND were associated with better prognosis in the whole cohort (P < 0.001). Patients who had positive lymph nodes were found to have the worst prognosis (P < 0.001). Restricted cubic spline (RCS) found that patients with at least 8 LNs examined show longer survival than those with nLNE < 8, which was further validated in multivariable Cox regression [HR 0.66 (0.59, 0.76)]. Subgroup analysis indicated that nLNE ≥ 8 was associated with significantly improved overall survival in T1 and Tis patients both before and after PSM, while for Ta patients, the impact of LND or nLNE ≥ 8 on prognosis was insignificant. Additionally, for patients with negative lymph node, nLNE ≥ 8 still resulted in better prognosis [HR 0.73 (0.61, 0.87)]. Furthermore, sensitivity analyses replicated the same results in patients more than 80 years old and found that patients with nLNE ≥ 8 demonstrated superior prognosis than those with less than 8 lymph nodes retrieved. Conclusions: Among patients with NMIBC, it is crucial to remove eight or more lymph node effectively during cystectomy, except in Ta subgroup.
- 10 July 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (12) , 9432-9444
Open AccessPrognostic Value of the Extent of Lymphadenectomy for Overall Survival Among Patients with Non-muscle Invasive Bladder Cancer, A Retrospective Cohort Study
Background: The purpose of this study was to find out the impact of lymph node dissection (LND) on the prognosis of patients undergoing cystectomy for non-muscle invasive bladder cancer (NMIBC) and determine the minimum number of lymph nodes (LNs) for resection. Patients and Methods: Patients with NMIBC undergoing cystectomy between 2004 and 2015 were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching and multivariate Cox regression analyses were performed to mitigate the influence of selection bias and control for potential confounding variables. Results: Of 1950 patients with NMIBC, 1353 underwent LND, of which 58 (4.2%) exhibited positive LNs. LND were associated with better prognosis in the whole cohort (P < 0.001). Patients who had positive lymph nodes were found to have the worst prognosis (P < 0.001). Restricted cubic spline (RCS) found that patients with at least 8 LNs examined show longer survival than those with nLNE < 8, which was further validated in multivariable Cox regression [HR 0.66 (0.59, 0.76)]. Subgroup analysis indicated that nLNE ≥ 8 was associated with significantly improved overall survival in T1 and Tis patients both before and after PSM, while for Ta patients, the impact of LND or nLNE ≥ 8 on prognosis was insignificant. Additionally, for patients with negative lymph node, nLNE ≥ 8 still resulted in better prognosis [HR 0.73 (0.61, 0.87)]. Furthermore, sensitivity analyses replicated the same results in patients more than 80 years old and found that patients with nLNE ≥ 8 demonstrated superior prognosis than those with less than 8 lymph nodes retrieved. Conclusions: Among patients with NMIBC, it is crucial to remove eight or more lymph node effectively during cystectomy, except in Ta subgroup.
- Open Access
- 4 June 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (7) , 4746-4755
Comparison of different segmental metal ureteral stents as maintenance therapy across different years in ureteral stricture management: a systematic review and meta-analysis
Background: Ureteral stent placement is a common treatment for relieving hydronephrosis due to ureteral strictures. Recently, segmental metal ureteral stents (MUSs) have emerged as a promising option. However, the efficacy and complications of different segmental MUSs remain controversial. Objective: To evaluate and compare the efficacy and safety of different segmental MUSs as the long-term maintenance therapy across different years for ureteral strictures caused by various etiologies. Methods: A systematic search of databases, including PubMed, Web of Science, and Embase, was conducted to identify studies that employed segmental MUSs. The primary success was defined as the absence of complications necessitating further intervention following successful stent placement and continued patency. The weighted pooled primary success rates of different segmental MUSs were calculated using R over three duration intervals: less than 1, 1–2, and more than 2 years. Results: A total of 31 studies, comprising 1660 cases, were included in the meta-analysis. The weighted pooled primary success rates for segmental MUSs were 73% (95% CI [70%, 77%], I 2 = 18%) for durations of less than 1 year, 66% (95% CI [56%, 75%], I 2 = 90%) for 1–2 years, and 39% (95% CI [23%, 55%], I 2 = 90%) for more than 2 years. The variation in stent types was identified as a significant source of heterogeneity. Notably, the Allium stent exhibited a primary success rate of 81% (95% CI [75%, 87%], I 2 = 63%) for the 1–2-year period, and 65% (95% CI [54%, 76%], I 2 = 0%) for durations exceeding 2 years, significantly outperforming both the Uventa (1–2 year: 51%; >2 year: 23%) and Memokath (1–2 year: 53%; >2 year: 23%) (P < 0.001). Moreover, covered stents demonstrated significantly greater efficacy than uncovered stents for 1–2 years (75% vs. 53%; P = 0.01). Complications leading to stent failure primarily included obstruction, migration, encrustation, and urinary tract infection. Conclusion: The safety and efficacy of various segmental MUSs as long-term maintenance therapy for ureteral strictures vary significantly. The Allium stent showing a marked advantage over other stents, making it a preferred choice for long-term management.
- 4 June 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (7) , 4746-4755
Open AccessComparison of different segmental metal ureteral stents as maintenance therapy across different years in ureteral stricture management: a systematic review and meta-analysis
Background: Ureteral stent placement is a common treatment for relieving hydronephrosis due to ureteral strictures. Recently, segmental metal ureteral stents (MUSs) have emerged as a promising option. However, the efficacy and complications of different segmental MUSs remain controversial. Objective: To evaluate and compare the efficacy and safety of different segmental MUSs as the long-term maintenance therapy across different years for ureteral strictures caused by various etiologies. Methods: A systematic search of databases, including PubMed, Web of Science, and Embase, was conducted to identify studies that employed segmental MUSs. The primary success was defined as the absence of complications necessitating further intervention following successful stent placement and continued patency. The weighted pooled primary success rates of different segmental MUSs were calculated using R over three duration intervals: less than 1, 1–2, and more than 2 years. Results: A total of 31 studies, comprising 1660 cases, were included in the meta-analysis. The weighted pooled primary success rates for segmental MUSs were 73% (95% CI [70%, 77%], I 2 = 18%) for durations of less than 1 year, 66% (95% CI [56%, 75%], I 2 = 90%) for 1–2 years, and 39% (95% CI [23%, 55%], I 2 = 90%) for more than 2 years. The variation in stent types was identified as a significant source of heterogeneity. Notably, the Allium stent exhibited a primary success rate of 81% (95% CI [75%, 87%], I 2 = 63%) for the 1–2-year period, and 65% (95% CI [54%, 76%], I 2 = 0%) for durations exceeding 2 years, significantly outperforming both the Uventa (1–2 year: 51%; >2 year: 23%) and Memokath (1–2 year: 53%; >2 year: 23%) (P < 0.001). Moreover, covered stents demonstrated significantly greater efficacy than uncovered stents for 1–2 years (75% vs. 53%; P = 0.01). Complications leading to stent failure primarily included obstruction, migration, encrustation, and urinary tract infection. Conclusion: The safety and efficacy of various segmental MUSs as long-term maintenance therapy for ureteral strictures vary significantly. The Allium stent showing a marked advantage over other stents, making it a preferred choice for long-term management.
- Open Access
- 1 March 2025
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 14 (3) , 669-677
Prognostic outcomes of surgical modalities and predictive factors for distant metastases in T1a renal cell carcinoma: a SEER database analysis
Background: Distant metastases can still occur in T1a renal cancer. There is no conclusive evidence to determine whether cytoreductive partial nephrectomy (cPN) or cytoreductive radical nephrectomy (cRN) is superior in managing primary renal lesions. This study aimed to compare survival outcomes between cPN and cRN in pathological T1a renal cell carcinoma (RCC) patients with distant metastases and to develop a predictive model for metastasis risk stratification. Methods: T1a RCC patients were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Prognostic comparisons were made using Kaplan-Meier analysis. Univariate and multivariate logistic regression analyses were conducted to assess the risk factors for distant metastases in T1a RCC, leading to the development of a predictive model. The model’s performance was evaluated using receiver operating characteristic (ROC) curves. Results: The study included 55,957 RCC patients with pathologic T1a, of which 1,496 (2.67%) with distant metastases. Metastatic patients exhibited significantly worse overall survival (OS) than non-metastatic counterparts (PConclusions: There was no significant difference in OS between cPN and cRN. Advanced age, male gender, poor histological differentiation, capsular invasion, sarcomatoid features, and lymph node metastasis were independent risk factors for distant metastases in RCC patients with stage T1a.
- 1 March 2025
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 14 (3) , 669-677
Open AccessPrognostic outcomes of surgical modalities and predictive factors for distant metastases in T1a renal cell carcinoma: a SEER database analysis
Background: Distant metastases can still occur in T1a renal cancer. There is no conclusive evidence to determine whether cytoreductive partial nephrectomy (cPN) or cytoreductive radical nephrectomy (cRN) is superior in managing primary renal lesions. This study aimed to compare survival outcomes between cPN and cRN in pathological T1a renal cell carcinoma (RCC) patients with distant metastases and to develop a predictive model for metastasis risk stratification. Methods: T1a RCC patients were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Prognostic comparisons were made using Kaplan-Meier analysis. Univariate and multivariate logistic regression analyses were conducted to assess the risk factors for distant metastases in T1a RCC, leading to the development of a predictive model. The model’s performance was evaluated using receiver operating characteristic (ROC) curves. Results: The study included 55,957 RCC patients with pathologic T1a, of which 1,496 (2.67%) with distant metastases. Metastatic patients exhibited significantly worse overall survival (OS) than non-metastatic counterparts (PConclusions: There was no significant difference in OS between cPN and cRN. Advanced age, male gender, poor histological differentiation, capsular invasion, sarcomatoid features, and lymph node metastasis were independent risk factors for distant metastases in RCC patients with stage T1a.
- Open Access
- 18 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Impact of upper tract urothelial carcinoma history on patients with non-muscle invasive bladder cancer undergoing intravesical chemotherapy
This study was designed to evaluate the impact of upper tract urothelial carcinoma (UTUC) history on prognosis in patients with non-muscle-invasive bladder cancer (NMIBC) receiving intravesical chemotherapy. We conducted a single center, retrospective, cohort study of 444 NMIBC patients who received intravesical chemotherapy after transurethral resection of the bladder cancer (TURBT) at Peking University People’s Hospital from 2000 to 2015. Patients were divided into UTUC-NMIBC group (with UTUC history) and primary NMIBC group (without UTUC history) by presence of previous UTUC. Demographic, clinical and pathologic factors were analyzed. Kaplan–Meier curves and the log-rank test were used to depict and compare recurrence-free survival (RFS) and progression-free survival (PFS) between the two groups. Multivariable Cox regression models were constructed to determine the variables associated with RFS and PFS. Compared to the primary NMIBC group (n = 410), the UTUC-NMIBC group (n = 34) had an older median age [72.0 (65.0–81.0) vs. 66.0 (58–75) years; P = 0.007], a higher incidence of multiple tumors (52.9% vs. 33.9%; P = 0.026) and a higher recurrence rate (52.9% vs. 30.7%; P = 0.008) and worse RFS (P < 0.001). In multivariate analysis, UTUC history was an independent risk factor for recurrence (hazard ratio = 2.242; P = 0.001), but not for progression. Interestingly, subgroup analysis indicated patients with recent UTUC history (≤ 24 months between UTUC and NMIBC diagnoses) were associated with increased recurrence rates (73.7% vs. 26.7%; P = 0.014). Presence of UTUC history was an independent risk factor for recurrence in patients with NMIBC who received intravesical chemotherapy, especially in those with a shorter interval between UTUC and NMIBC diagnoses.
- 18 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Open AccessImpact of upper tract urothelial carcinoma history on patients with non-muscle invasive bladder cancer undergoing intravesical chemotherapy
This study was designed to evaluate the impact of upper tract urothelial carcinoma (UTUC) history on prognosis in patients with non-muscle-invasive bladder cancer (NMIBC) receiving intravesical chemotherapy. We conducted a single center, retrospective, cohort study of 444 NMIBC patients who received intravesical chemotherapy after transurethral resection of the bladder cancer (TURBT) at Peking University People’s Hospital from 2000 to 2015. Patients were divided into UTUC-NMIBC group (with UTUC history) and primary NMIBC group (without UTUC history) by presence of previous UTUC. Demographic, clinical and pathologic factors were analyzed. Kaplan–Meier curves and the log-rank test were used to depict and compare recurrence-free survival (RFS) and progression-free survival (PFS) between the two groups. Multivariable Cox regression models were constructed to determine the variables associated with RFS and PFS. Compared to the primary NMIBC group (n = 410), the UTUC-NMIBC group (n = 34) had an older median age [72.0 (65.0–81.0) vs. 66.0 (58–75) years; P = 0.007], a higher incidence of multiple tumors (52.9% vs. 33.9%; P = 0.026) and a higher recurrence rate (52.9% vs. 30.7%; P = 0.008) and worse RFS (P < 0.001). In multivariate analysis, UTUC history was an independent risk factor for recurrence (hazard ratio = 2.242; P = 0.001), but not for progression. Interestingly, subgroup analysis indicated patients with recent UTUC history (≤ 24 months between UTUC and NMIBC diagnoses) were associated with increased recurrence rates (73.7% vs. 26.7%; P = 0.014). Presence of UTUC history was an independent risk factor for recurrence in patients with NMIBC who received intravesical chemotherapy, especially in those with a shorter interval between UTUC and NMIBC diagnoses.